Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range
New York, June 10, 2026, 05:04 PM ET Parabilis Medicines jumped in its Nasdaq debut Wednesday. Shares opened under PBLS and closed at $31.60, up 58% from the $20 IPO price. The company had priced a bigger-than-expected $670 million initial offering, topping the marketed range. Investors chased the deal harder than Parabilis suggested just a day before.
